28266177|t|TNF-α promotes survival and migration of MSCs under oxidative stress via NF-κB pathway to attenuate intimal hyperplasia in vein grafts
28266177|a|The oxidative stress caused by endothelial injury is involved in intimal hyperplasia (IH) in vein grafts. Mesenchymal stem cells (MSCs) can home to injured intima and promote endothelial repair. However, MSC apoptosis is increased accompanied by decreased functional activity under oxidative stress. Thus, we investigate whether tumour necrosis factor-α (TNF-α) can promote the survival and activity of MSCs under oxidative stress to reduce IH more effectively, and establish what role the NF-κB pathway plays in this. In this study, we preconditioned MSCs with TNF-α ((TNF)(-α-PC) MSCs) for 24 hrs and measured the activation of the IKK / NF-κB pathway. EdU and transwell assays were performed to assess proliferation and migration of (TNF)(-α-PC) MSCs. Apoptosis and migration of (TNF)(-α-)(PC) MSCs were evaluated in conditions of oxidative stress by analysis of the expression of Bcl-2 and CXCR4 proteins. (TNF)(-α-)(PC) MSCs were transplanted into a vein graft model, so that cell homing could be tracked, and endothelial apoptosis and IH of vein grafts were measured. The results demonstrated that TNF-α promotes proliferation and migration of MSCs. Furthermore, survival and migration of (TNF)(-α-)(PC) MSCs under oxidative stress were both enhanced. A greater number of MSCs migrated to the intima of vein grafts after preconditioning with TNF-α, and the formation of neointima was significantly reduced. These effects could be partially abolished by IKK XII (NF-κB inhibitor). All these results indicate that preconditioning with TNF-α can promote survival and migration of MSCs under oxidative stress via the NF-κB pathway and thus attenuate IH of vein grafts.
28266177	0	5	TNF-α	T103	UMLS:C1456820
28266177	15	23	survival	T038	UMLS:C0007620
28266177	28	37	migration	T038	UMLS:C1622501
28266177	41	45	MSCs	T017	UMLS:C1257975
28266177	52	68	oxidative stress	T038	UMLS:C0242606
28266177	73	86	NF-κB pathway	T038	UMLS:C1513838
28266177	100	119	intimal hyperplasia	T038	UMLS:C3854573
28266177	123	134	vein grafts	T017	UMLS:C0440763
28266177	139	155	oxidative stress	T038	UMLS:C0242606
28266177	166	177	endothelial	T017	UMLS:C0014257
28266177	178	184	injury	T037	UMLS:C3263723
28266177	200	219	intimal hyperplasia	T038	UMLS:C3854573
28266177	221	223	IH	T038	UMLS:C3854573
28266177	228	239	vein grafts	T017	UMLS:C0440763
28266177	241	263	Mesenchymal stem cells	T017	UMLS:C1257975
28266177	265	269	MSCs	T017	UMLS:C1257975
28266177	291	297	intima	T017	UMLS:C1256463
28266177	310	321	endothelial	T017	UMLS:C0014257
28266177	322	328	repair	T058	UMLS:C1705181
28266177	339	342	MSC	T017	UMLS:C1257975
28266177	343	352	apoptosis	T038	UMLS:C0162638
28266177	417	433	oxidative stress	T038	UMLS:C0242606
28266177	464	488	tumour necrosis factor-α	T103	UMLS:C1456820
28266177	490	495	TNF-α	T103	UMLS:C1456820
28266177	513	521	survival	T038	UMLS:C0007620
28266177	538	542	MSCs	T017	UMLS:C1257975
28266177	549	565	oxidative stress	T038	UMLS:C0242606
28266177	576	578	IH	T038	UMLS:C3854573
28266177	625	638	NF-κB pathway	T038	UMLS:C1513838
28266177	662	667	study	T062	UMLS:C2603343
28266177	687	691	MSCs	T017	UMLS:C1257975
28266177	697	702	TNF-α	T103	UMLS:C1456820
28266177	704	721	(TNF)(-α-PC) MSCs	T017	UMLS:C1257975
28266177	769	772	IKK	T103	UMLS:C0663914
28266177	775	788	NF-κB pathway	T038	UMLS:C1513838
28266177	790	793	EdU	T103	UMLS:C0613970
28266177	798	814	transwell assays	T058	UMLS:C1510438
28266177	840	853	proliferation	T038	UMLS:C0596290
28266177	858	867	migration	T038	UMLS:C1622501
28266177	871	888	(TNF)(-α-PC) MSCs	T017	UMLS:C1257975
28266177	890	899	Apoptosis	T038	UMLS:C0162638
28266177	904	913	migration	T038	UMLS:C1622501
28266177	917	936	(TNF)(-α-)(PC) MSCs	T017	UMLS:C1257975
28266177	942	951	evaluated	T058	UMLS:C0220825
28266177	969	985	oxidative stress	T038	UMLS:C0242606
28266177	989	997	analysis	T062	UMLS:C0936012
28266177	1005	1015	expression	T038	UMLS:C1171362
28266177	1019	1024	Bcl-2	T103	UMLS:C4042483
28266177	1029	1043	CXCR4 proteins	T103	UMLS:C2352110
28266177	1045	1064	(TNF)(-α-)(PC) MSCs	T017	UMLS:C1257975
28266177	1070	1082	transplanted	T058	UMLS:C0040732
28266177	1090	1106	vein graft model	T017	UMLS:C0440763
28266177	1116	1127	cell homing	T038	UMLS:C0007613
28266177	1137	1144	tracked	T082	UMLS:C0546881
28266177	1150	1161	endothelial	T017	UMLS:C0014257
28266177	1162	1171	apoptosis	T038	UMLS:C0162638
28266177	1176	1178	IH	T038	UMLS:C3854573
28266177	1182	1193	vein grafts	T017	UMLS:C0440763
28266177	1239	1244	TNF-α	T103	UMLS:C1456820
28266177	1254	1267	proliferation	T038	UMLS:C0596290
28266177	1272	1281	migration	T038	UMLS:C1622501
28266177	1285	1289	MSCs	T017	UMLS:C1257975
28266177	1304	1312	survival	T038	UMLS:C0007620
28266177	1317	1326	migration	T038	UMLS:C1622501
28266177	1330	1349	(TNF)(-α-)(PC) MSCs	T017	UMLS:C1257975
28266177	1356	1372	oxidative stress	T038	UMLS:C0242606
28266177	1413	1417	MSCs	T017	UMLS:C1257975
28266177	1418	1426	migrated	T038	UMLS:C1622501
28266177	1434	1440	intima	T017	UMLS:C1256463
28266177	1444	1455	vein grafts	T017	UMLS:C0440763
28266177	1483	1488	TNF-α	T103	UMLS:C1456820
28266177	1511	1520	neointima	T017	UMLS:C2936380
28266177	1594	1601	IKK XII	T038	UMLS:C1818972
28266177	1603	1618	NF-κB inhibitor	T038	UMLS:C1818972
28266177	1674	1679	TNF-α	T103	UMLS:C1456820
28266177	1692	1700	survival	T038	UMLS:C0007620
28266177	1705	1714	migration	T038	UMLS:C1622501
28266177	1718	1722	MSCs	T017	UMLS:C1257975
28266177	1729	1745	oxidative stress	T038	UMLS:C0242606
28266177	1754	1767	NF-κB pathway	T038	UMLS:C1513838
28266177	1787	1789	IH	T038	UMLS:C3854573
28266177	1793	1804	vein grafts	T017	UMLS:C0440763